Lupin gets USFDA nod for Asthma drug

Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.

Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news